PLX Pharma Inc. (NASDAQ:PLXP): Peter S. Park’s Park West Asset Management filed an amended 13D.
You can check out Park West Asset Management’s latest holdings and filings here.
Please follow Park West Asset Management (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Park West Asset Management or update its stock holdings.
You can access the original SEC filing by clicking here.
Ownership Summary Table
|Name||Sole Voting Power||Shared Voting Power||Sole Dispositive Power||Shared Dispositive Power||Aggregate Amount Owned Power||Percent of Class|
|Park West Asset Management||0||1,075,723||0||1,075,723||1,075,723||12.3%|
|Park West Investors Master Fund, Limited||0||953,465||0||953,465||953,465||10.9%|
|Peter S. Park||0||1,075,723||0||1,075,723||1,075,723||12.3%|
Page 1 of 10 – SEC Filing
AND EXCHANGE COMMISSION
EXCHANGE ACT OF 1934
(Amendment No. )*
|(Name of Issuer)|
Stock, $0.001 par value per share
|(Title of Class of |
|(Date of Event Which |
Requires Filing of this Statement)
|If the filing person has previously |
filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule
because of §240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [x].
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided
in a prior cover page.